# BioIVT LLC – FDA Inspection, Aug 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/bioivt-llc/1cea3536-af14-4e3d-831b-b6bfb5b38aba
Source feed: FDA_Inspections

> FDA inspection 1217251 of BioIVT LLC, August 23, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217251
- Company Name: BioIVT LLC
- Inspection Date: 2023-08-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1341618 - 2026-09-30
- FDA Inspection 1100353 - 2019-07-18
- FDA Inspection 926277 - 2015-05-14
- [FDA Inspection 736628 - 2011-07-28](https://www.keypedia.com/records/fda_inspections/bioivt-llc/9f680cb7-1ca5-48c3-9311-6ccfd635eafe)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)

Company: https://www.keypedia.com/companies/bioivt-llc/6ccbe686-dec4-4ba7-aa07-2c5f5fc83193

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d